Page last updated: 2024-10-31

nafamostat and Vascular Diseases

nafamostat has been researched along with Vascular Diseases in 3 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsuda, Y1
Nakahara, T1
Ueda, K1
Mori, A1
Sakamoto, K1
Ishii, K1
Ishimaru, K1
Mitsuoka, H1
Unno, N1
Inuzuka, K1
Nakamura, S1
Schmid-Schönbein, GW1
Teraoka, S1
Takahashi, K1
Toma, H1
Yagisawa, T1
Yamaguchi, Y1
Sanaka, T1
Fuchinoue, S1
Honda, H1
Kawai, T1
Tanabe, K1

Other Studies

3 other studies available for nafamostat and Vascular Diseases

ArticleYear
Effect of nafamostat on N-methyl-D-aspartate-induced retinal neuronal and capillary degeneration in rats.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:12

    Topics: Animals; Basement Membrane; Benzamidines; Capillaries; Diabetic Neuropathies; Excitatory Amino Acid

2012
Pancreatic proteases and inflammatory mediators in peritoneal fluid during splanchnic arterial occlusion and reperfusion.
    Shock (Augusta, Ga.), 2004, Volume: 22, Issue:5

    Topics: Animals; Arteries; Benzamidines; Blood Pressure; Cardiovascular System; Endopeptidases; Enzyme Inhib

2004
New approach to management of chronic vascular rejection with prostacyclin analogue after kidney transplantation.
    Transplantation proceedings, 1987, Volume: 19, Issue:1 Pt 3

    Topics: alpha-Cyclodextrins; Benzamidines; Blood Platelets; Cyclodextrins; Epoprostenol; Esters; Gabexate; G

1987